Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by alnovaon May 22, 2018 8:11am

184 Views

Post# 28062236

RE: RE: AWARENESS

Recent news on IRB approval, location of trial with a renowned clinical investigator, new CFO, recent corporate presentation on company website, and trading at a five month low!!! Although investing in this company would still at this point be speculative, the rewards could be quite substantial should they get good preliminary results from clinical trial, or secure some form of deal, licencing, collaboration or partnership with a large player in the field. So my question is. Where are the speculators?? Need AWARENESS!! Good luck to all current shareholders.

Bullboard Posts

Visionstate set to leverage success in the U.S. market